149 related articles for article (PubMed ID: 31933104)
1. Neuroprotection of SAK3 on scopolamine-induced cholinergic dysfunction in human neuroblastoma SH-SY5Y cells.
Suthprasertporn N; Mingchinda N; Fukunaga K; Thangnipon W
Cytotechnology; 2020 Feb; 72(1):155-164. PubMed ID: 31933104
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotection of
Puangmalai N; Thangnipon W; Soi-Ampornkul R; Suwanna N; Tuchinda P; Nobsathian S
Neural Regen Res; 2017 Sep; 12(9):1492-1498. PubMed ID: 29089996
[TBL] [Abstract][Full Text] [Related]
3. SAK3 Administration Improves Spine Abnormalities and Cognitive Deficits in App
Izumi H; Kawahata I; Shinoda Y; Helmstetter FJ; Fukunaga K
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32481611
[TBL] [Abstract][Full Text] [Related]
4. T-type calcium channel enhancer SAK3 promotes dopamine and serotonin releases in the hippocampus in naive and amyloid precursor protein knock-in mice.
Wang S; Yabuki Y; Matsuo K; Xu J; Izumi H; Sakimura K; Saito T; Saido TC; Fukunaga K
PLoS One; 2018; 13(12):e0206986. PubMed ID: 30571684
[TBL] [Abstract][Full Text] [Related]
5. Single Administration of the T-Type Calcium Channel Enhancer SAK3 Reduces Oxidative Stress and Improves Cognition in Olfactory Bulbectomized Mice.
Yuan D; Cheng A; Kawahata I; Izumi H; Xu J; Fukunaga K
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33451040
[TBL] [Abstract][Full Text] [Related]
6. T-Type Ca
Xu J; Kawahata I; Izumi H; Fukunaga K
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34201181
[TBL] [Abstract][Full Text] [Related]
7. The Disease-modifying Drug Candidate, SAK3 Improves Cognitive Impairment and Inhibits Amyloid beta Deposition in App Knock-in Mice.
Izumi H; Shinoda Y; Saito T; Saido TC; Sato K; Yabuki Y; Matsumoto Y; Kanemitsu Y; Tomioka Y; Abolhassani N; Nakabeppu Y; Fukunaga K
Neuroscience; 2018 May; 377():87-97. PubMed ID: 29510211
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological properties of SAK3, a novel T-type voltage-gated Ca
Yabuki Y; Matsuo K; Izumi H; Haga H; Yoshida T; Wakamori M; Kakei A; Sakimura K; Fukuda T; Fukunaga K
Neuropharmacology; 2017 May; 117():1-13. PubMed ID: 28093211
[TBL] [Abstract][Full Text] [Related]
9. The T-type calcium channel enhancer SAK3 inhibits neuronal death following transient brain ischemia via nicotinic acetylcholine receptor stimulation.
Yabuki Y; Jing X; Fukunaga K
Neurochem Int; 2017 Sep; 108():272-281. PubMed ID: 28457878
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of diarylpropionitrile against hydrogen peroxide-induced damage in human neuroblastoma SH-SY5Y cells.
Suthprasertporn N; Suwanna N; Thangnipon W
Drug Chem Toxicol; 2022 Jan; 45(1):44-51. PubMed ID: 31495239
[TBL] [Abstract][Full Text] [Related]
11. The role of GLP-1/GIP receptor agonists in Alzheimer's disease.
Yu CJ; Ma D; Song LL; Zhai ZN; Tao Y; Zhang Y; Cai LY; Hou YH; Chen HY; Wang L
Adv Clin Exp Med; 2020 Jun; 29(6):661-668. PubMed ID: 32614526
[TBL] [Abstract][Full Text] [Related]
12. MiR-340 Reduces the Accumulation of Amyloid-β Through Targeting BACE1 (β-site Amyloid Precursor Protein Cleaving Enzyme 1) in Alzheimer's Disease.
Tan X; Luo Y; Pi D; Xia L; Li Z; Tu Q
Curr Neurovasc Res; 2020; 17(1):86-92. PubMed ID: 31957613
[TBL] [Abstract][Full Text] [Related]
13. The protective underlying mechanisms of Schisandrin on SH-SY5Y cell model of Alzheimer's disease.
Zhao ZY; Zhang YQ; Zhang YH; Wei XZ; Wang H; Zhang M; Yang ZJ; Zhang CH
J Toxicol Environ Health A; 2019; 82(19):1019-1026. PubMed ID: 31739764
[TBL] [Abstract][Full Text] [Related]
14. [miR-155-5p alleviates lipopolysaccharide-induced inflammatory damage of human SH-SY5Y neuroblastoma cells by down-regulating SOCS1].
Zhou H; Zhou L; Zhang C; Zhou L; Han Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Mar; 39(3):220-229. PubMed ID: 36946346
[TBL] [Abstract][Full Text] [Related]
15. A Novel Compound YS-5-23 Exhibits Neuroprotective Effect by Reducing β-Site Amyloid Precursor Protein Cleaving Enzyme 1's Expression and H
Cheng C; Zheng N; Sun D; Fang W; Zheng L; Song W; Huang J
Neurochem Res; 2020 Sep; 45(9):2113-2127. PubMed ID: 32556702
[TBL] [Abstract][Full Text] [Related]
16. Caniferolide A, a Macrolide from Streptomyces caniferus, Attenuates Neuroinflammation, Oxidative Stress, Amyloid-Beta, and Tau Pathology in Vitro.
Alvariño R; Alonso E; Lacret R; Oves-Costales D; Genilloud O; Reyes F; Alfonso A; Botana LM
Mol Pharm; 2019 Apr; 16(4):1456-1466. PubMed ID: 30821469
[TBL] [Abstract][Full Text] [Related]
17. Vitegnoside Mitigates Neuronal Injury, Mitochondrial Apoptosis, and Inflammation in an Alzheimer's Disease Cell Model via the p38 MAPK/JNK Pathway.
Wang Q; Jiang H; Wang L; Yi H; Li Z; Liu R
J Alzheimers Dis; 2019; 72(1):199-214. PubMed ID: 31561371
[TBL] [Abstract][Full Text] [Related]
18. Altered processing of the amyloid precursor protein and decreased expression of ADAM 10 by chronic hypoxia in SH-SY5Y: no role for the stress-activated JNK and p38 signalling pathways.
Webster NJ; Green KN; Settle VJ; Peers C; Vaughan PF
Brain Res Mol Brain Res; 2004 Nov; 130(1-2):161-9. PubMed ID: 15519686
[TBL] [Abstract][Full Text] [Related]
19. Carvacrol protects neuroblastoma SH-SY5Y cells against Fe(2+)-induced apoptosis by suppressing activation of MAPK/JNK-NF-κB signaling pathway.
Cui ZW; Xie ZX; Wang BF; Zhong ZH; Chen XY; Sun YH; Sun QF; Yang GY; Bian LG
Acta Pharmacol Sin; 2015 Dec; 36(12):1426-36. PubMed ID: 26592517
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
